thynC and mobiCARE Remote Patient Monitoring

SEERS Technology is a South Korean medical technology company founded in 2009 by CEO Lee Young-shin and listed on KOSDAQ. Headquartered in Pyeongtaek with an R&D centre in Seongnam, it builds wearable biosensor-based diagnosis and monitoring solutions so that hospitals can follow patients continuously instead of relying on periodic manual checks.

thynC is an end-to-end inpatient monitoring solution: wireless wearable biosensors, a gateway that streams data continuously, a ward dashboard and mobile dashboard that flag abnormal vital signs in real time, and an AI system that tracks trends in patient condition. mobiCARE is a wearable Holter ECG service with clinically validated analysis software that produces reports to support arrhythmia diagnosis. Customers are hospitals and clinics; by late 2025 thynC was installed in 107 hospitals with about 11,200 beds in Korea.

• Wearable biosensor: wireless sensor designed to be worn for extended periods to collect biological data.
• Continuous gateway: collects and transmits patient data without interruption from the ward.
• Ward dashboard: shows abnormal real-time vital information for all monitored patients at a glance.
• Mobile dashboard: lets clinicians check essential patient information from a phone.
• AI trend analysis: tracks changes in patient condition over time to support early intervention.
• mobiCARE ECG reports: wearable Holter with validated algorithm-based analysis for arrhythmia diagnosis.

A provincial general hospital in Vietnam could equip internal medicine and post-surgery wards with wearable sensors so nurses see deteriorating patients on a central dashboard. Cardiology clinics could use mobiCARE patches instead of conventional Holter devices for outpatient arrhythmia screening. Private hospital groups could pilot smart wards before rolling out across branches.

Gives nurses continuous visibility of every monitored bed, reducing gaps between manual vital-sign rounds. Shows abnormal readings at a glance on ward and mobile dashboards so staff can act earlier. Replaces bulky Holter workflows with a wearable ECG patch plus software-generated arrhythmia reports. Scales per bed, which suits hospitals that want to extend monitoring beyond the ICU.

Hospitals in Asia face nursing shortages and rising numbers of elderly inpatients, which pushes demand for continuous wireless monitoring in general wards rather than only in intensive care. Korean providers are also exporting remote monitoring models to other Asian countries, and Southeast Asian hospitals building smart wards are a natural market for per-bed monitoring systems.

Founded in 2009, headquartered in Pyeongtaek, South Korea, and listed on KOSDAQ in 2024. Daewoong Pharmaceutical holds domestic sales rights for thynC. Overseas pilots include a thynC installation at a cardiology centre of Mongolia's Third National Hospital. Main sponsor of the Asian Telemedicine Society conference ATS 2025.